We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
DSFIR.AS

Price
97.88
Stock movement down
-0.22 (-0.22%)
Company name
DSM-Firmenich AG
Exchange
(AS
,
Currency
EUR
)
Sector
Basic Materials >
Specialty Chemicals
Markedsverdi
25.97B
Ent verdi
34.71B
Pris/omsetning
2.02
Pris/bok
1.13
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
27.47%
Etterfølgende P/E
-
Fremtidig P/E
32.30
PEG
-
EPS-vekst
-
1 års avkastning
6.22%
3 års avkastning
-
5 års avkastning
-
10 års avkastning
-
Sist oppdatert: 2024-12-21

UTBYTTE

DSFIR.AS betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF18.32
Pris til FCF45.43
Pris til EBITDA64.83
EV i forhold til EBITDA86.67

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning2.02
Pris til bok1.13
EV i forhold til salg2.70

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall265.28M
EPS (TTM)-3.25
FCF per aksje (TTM)2.15

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)12.86B
Bruttofortjeneste (TTM)3.57B
Driftsinntekter (TTM)-427.50M
Netto inntekt (TTM)-865.00M
EPS (TTM)-3.25
EPS (1 år fremover)3.03

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)27.76%
Driftsmargin (TTM)-3.32%
Fortjenestemargin (TTM)-6.73%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter2.46B
Netto fordringer2.55B
Samlede omløpsmidler8.84B
Goodwill11.29B
Immaterielle eiendeler7.45B
Eiendom, anlegg og utstyr0.00
Sum eiendeler34.27B
Leverandørgjeld2.07B
Kortsiktig/nåværende langsiktig gjeld4.83B
Sum kortsiktig gjeld4.52B
Sum gjeld11.20B
Aksjonærenes egenkapital23.07B
Netto varige driftsmidler0.00

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)1.42B
Kapitalutgifter (TTM)846.00M
Fri kontantstrøm (TTM)571.50M
Utbetalt utbytte (TTM)157.00M

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-3.75%
Avkastning på eiendeler-2.52%
Avkastning på investert kapital-3.64%
Kontantavkastning på investert kapital2.40%

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning97.92
Daglig høy98.86
Daglig lav97.08
Daglig volum851K
Tidenes høyeste123.65
1 år analytikerestimat132.20
Beta-
EPS (TTM)-3.25
Utbytte per aksje-
Ex-div dato9 May 2024
Neste dato for resultatpresentasjon13 Feb 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
DSFIR.ASS&P500
Nåværende prisfall fra toppnotering-20.84%-2.74%
Høyeste prisfall-36.94%-56.47%
Dato for høyeste fall24 Oct 20239 Mar 2009
Gj.snittlig fall fra topp-16.86%-11.13%
Gj.snittlig tid til ny topp108 days12 days
Maks tid til ny topp346 days1805 days
SELSKAPSOPPLYSNINGER
DSFIR.AS (DSM-Firmenich AG) company logo
Markedsverdi
25.97B
Markedsverdi kategori
Large-cap
Beskrivelse
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes and yeast extracts solutions. The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision services for the animal production industry. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets. This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
Ansatte
27926
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
Netherlands
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
Key Insights DSM-Firmenich's estimated fair value is €115 based on 2 Stage Free Cash Flow to Equity Current share price...
11. november 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor confer...
26. september 2024
Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventMAASTRICHT, The Netherlands, Sept. 23, 2024 (GLOBE NEWSWIRE) -- dsm-firmenich...
23. september 2024
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday, Septembe...
19. september 2024
Key Insights DSM-Firmenich's significant retail investors ownership suggests that the key decisions are influenced by...
12. august 2024
Key Insights DSM-Firmenich's estimated fair value is €119 based on 2 Stage Free Cash Flow to Equity With €101 share...
4. juni 2024
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DSM Firmenich AG ...
4. april 2024
Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power...
4. mars 2024
Key Insights Using the 2 Stage Free Cash Flow to Equity, DSM-Firmenich fair value estimate is €114 With €91.43 share...
27. desember 2023